How AI is Transforming Medicine, Therapy, and Wellness
Gibbons writes with the authority of someone who has actually read the papers, worked in the industries, and thought hard about what it all means. This is not a book by someone who read three articles and wrote a hot take.
— Early reader review
More reviews incoming — this book launched in 2026.
From the synthetic confidant whispering through your AirPods at 2 AM, to the $7 trillion empire selling you expensive pee — a complete map of the AI-medicine collision.
"The outsourcing of emotional regulation"
Millions of people — insomniacs, survivors, the lonely — are quietly turning to AI chatbots for therapy and emotional support. Between 15–24% of active AI users do so already. Gibbons argues the real scandal isn't that the machine is answering; it's that the market has failed so badly that tens of millions have nobody else to ask.
🧠 Mental Health & AI"The clinical triumvirate and the end of the knowledge monopoly"
Gibbons arrives at his cardiologist's appointment armed with ten years of labs, an aortic root question, and a ChatGPT analysis — and is not well received. This chapter dissects the rise of the clinical triumvirate: patient, doctor, and machine.
⚕️ Diagnostic AI"Peptides, self-doctoring, and the bodily autonomy wars"
On a couch in Costa Rica, Gibbons watches his 36-year-old friend inject ipamorelin — a growth hormone secretagogue — while watching White Lotus. The central question of 2026: who owns your biology — you, your doctor, or the state?
💉 Biohacking & Autonomy"The revolution we didn't see coming"
GLP-1 receptor agonists were developed for Type II diabetes. They turned out to be something far stranger. Beyond 15–20% weight loss, they dampen the reward circuitry itself — silencing not just food cravings but all appetitive impulse. Patients report a peculiar "identity lag": the body changes faster than the mind can update.
💊 Metabolic Revolution"Bodily freedom or public health menace?"
A $5.6 trillion parallel medical universe promises energy, immunity, longevity, and detoxification — with zero obligation to prove it works. Gibbons dissects the four distortions that power the influencer economy: the naturalistic fallacy, the biochemical slaughterhouse, the mechanistic fallacy, and the prestige-price placebo.
📢 Wellness & EpistemicsFour findings from the book that challenge conventional wisdom — each grounded in peer-reviewed research.
The first randomised controlled trial of a generative AI chatbot showed depression symptom reductions statistically indistinguishable from standard human-delivered Cognitive Behavioural Therapy.
A blinded panel of licensed healthcare professionals evaluated written responses to patient questions. Nearly 80% preferred the AI responses, rated significantly higher for empathy.
Specialized AI models trained on millions of labelled ECG images detect occlusion MIs with 97% sensitivity. Human cardiologists miss approximately 1 in 7.
The SELECT Trial proved semaglutide reduced major cardiovascular events by 20% in obese patients — with improvements appearing long before significant weight loss.
Available now in Kindle, paperback, and hardcover.
Each volume maps a domain of turbulence. The real story is in the feedback loops between them.
AI and therapy, self-doctoring, peptides and biohacking, GLP-1s as identity editors, and the Wellness-Industrial Complex.
✦ You are hereAlien minds, cognitive infrastructure, world models, and recursive self-directed learning.
Geopolitics meets high-frequency trading, valuation hallucinations, and asset apartheid.
The dysrational enterprise, the agentic bottleneck, and the inversion of expertise.
Oracle science, the scientific trust gap, geo-solar engineering, and finally fusion.
The question we need to ask as a society isn't why the machine is answering, but why so many adults and teens are asking. The AI has merely uncorked the bottle of distress.
Paul Gibbons · Chapter I.1: Empathy as a Service